Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis

Pharmacokinetics of Favipiravir in Critically Ill Patients with COVID‐19

(2020) Kei Irie et al.   CTS-Clinical and Translational Science

A Review of Coronavirus Disease-2019 (COVID-19)

(2020) Tanu Singhal   INDIAN JOURNAL OF PEDIATRICS

Non‐steroidal anti‐inflammatory drugs in management of COVID‐19; a systematic review on current evidence

(2020) Mahmoud Yousefifard et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)

(2020) James M. Sanders et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Favipiravir, an antiviral for COVID-19?

(2020) Eric A Coomes et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study

(2020) Qingxian Cai et al.   Engineering

AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II/III Multicenter Randomized Clinical Trial

(2020) Andrey A Ivashchenko et al.   CLINICAL INFECTIOUS DISEASES

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

(2013) Alessandro Liberati   ANNALS OF INTERNAL MEDICINE